Pathophysiology of Thoracic Aortic Aneurysm (TAA): Is It Not One Uniform Aorta? Role of Embryologic Origin

National Center for Injury Prevention and Control. WISQARS Leading Causes of Death Reports, 1999–2006. Available at, http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html. Coady, 1999, Developing surgical intervention criteria for thoracic aortic aneurysms, Card Clin, 17, 827, 10.1016/S0733-8651(05)70118-1 Ruddy, 2008, Regional heterogeneity within the aorta: relevance to aneurysm disease, J Thorac Cardiovasc Surg, 136, 1123, 10.1016/j.jtcvs.2008.06.027 Castellano, 2012, Are we ignoring the dilated thoracic aorta?, Ann N Y Acad Sci, 1254, 164, 10.1111/j.1749-6632.2012.06493.x Wolinsky, 1970, Comparison of medial growth of human thoracic and abdominal aortas, Circ Res, 27, 531, 10.1161/01.RES.27.4.531 Halloran, 1995, Localization of aortic disease is associated with intrinsic differences in aortic structure, J Surg Res, 59, 17, 10.1006/jsre.1995.1126 Steed, 2011, Mechanisms of cardiovascular remodeling in hyperhomocysteinemia, Antiox Redox Sign, 15, 1927, 10.1089/ars.2010.3721 Zhou, 2009, Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms, Biofactors, 35, 120, 10.1002/biof.17 Steed, 2010, Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS−/−, and iNOS−/− mice, Am J Physiol Lung Cell Mol Physiol, 299, L301, 10.1152/ajplung.00065.2010 Dalton, 1997, Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells, FASEB, 11, 703, 10.1096/fasebj.11.8.9240971 Jones, 2006, Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm, J Vasc Surg, 44, 1314, 10.1016/j.jvs.2006.07.042 Bruemmer, 2011, Relevance of angiotensin II-induced aortic pathologies in mice to human aortic aneurysms, Ann N Y Acad Sci, 1245, 7, 10.1111/j.1749-6632.2011.06332.x Rateri, 2011, Prolonged infusion of angiotensin II in apoE(−/−) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm, Am J Pathol, 179, 1542, 10.1016/j.ajpath.2011.05.049 Beck, 1997, Vascular development: cellular and molecular regulation, FASEB, 11, 365, 10.1096/fasebj.11.5.9141503 Gadson, 1997, Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes, Ex Cell Res, 230, 169, 10.1006/excr.1996.3398 Thieszen, 1996, Embryonic lineage of vascular smooth muscle cells determines responses to collagen matrices and integrin receptor expression, Exp Cell Res, 227, 135, 10.1006/excr.1996.0258 El-Hamamsy, 2009, Cellular and molecular mechanisms of thoracic aortic aneurysms, Nature Rev Cardiology, 6, 771, 10.1038/nrcardio.2009.191 Wrana, 1994, Mechanism of activation of the TGF-beta receptor, Nature, 370, 341, 10.1038/370341a0 Leivonen, 2002, Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways, J Biol Chem, 277, 46338, 10.1074/jbc.M206535200 Kucich, 2002, Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38, Am J Resp Cell Mol Biol, 26, 183, 10.1165/ajrcmb.26.2.4666 Kwak, 2006, Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells, MCR, 4, 209, 10.1158/1541-7786.MCR-05-0140 Kim, 2004, TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells, Int Journal Oncol, 25, 1375 Holm, 2011, Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice, Science, 332, 358, 10.1126/science.1192149 Feng, 2005, Specificity and versatility in tgf-beta signaling through Smads, Ann Rev Cell Devel Biol, 21, 659, 10.1146/annurev.cellbio.21.022404.142018 Suszko, 2006, Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability, J Mol Endocrinol, 36, 591, 10.1677/jme.1.01936 Barbour, 2007, Proteinase systems and thoracic aortic aneurysm progression, J Surg Res, 139, 292, 10.1016/j.jss.2006.09.020 Sinha, 2006, A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2, J Vasc Surg, 43, 342, 10.1016/j.jvs.2005.10.013 Laiho, 1986, Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts, Exp Cell Res, 164, 399, 10.1016/0014-4827(86)90038-8 Sherratt, 2003, Fibrillin microfibrils are stiff reinforcing fibres in compliant tissues, J Mol Biol, 332, 183, 10.1016/S0022-2836(03)00829-5 Chaudhry, 2007, Fibrillin-1 regulates the bioavailability of TGFbeta1, J Cell Biol, 176, 355, 10.1083/jcb.200608167 Bax, 2007, Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation, J Cell Sci, 120, 1383, 10.1242/jcs.003954 van der Rest, 1991, Collagen family of proteins, FASEB, 5, 2814, 10.1096/fasebj.5.13.1916105 Goel, 2012, Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-beta/Smad3-treated medial smooth muscle cells, Cell Sign, 25, 955, 10.1016/j.cellsig.2012.12.021 Dietz, 2005, Recent progress towards a molecular understanding of Marfan syndrome, Am J Med Gen, 139C, 4, 10.1002/ajmg.c.30068 De Paepe, 1996, Revised diagnostic criteria for the Marfan syndrome, Am J Med Gen, 62, 417, 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R van Karnebeek, 2001, Natural history of cardiovascular manifestations in Marfan syndrome, Arch Dis Child, 84, 129, 10.1136/adc.84.2.129 Bunton, 2001, Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome, Circ Res, 88, 37, 10.1161/01.RES.88.1.37 Neptune, 2003, Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome, Nature Gen, 33, 407, 10.1038/ng1116 Habashi, 2006, Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome, Science, 312, 117, 10.1126/science.1124287 Habashi, 2011, Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism, Science, 332, 361, 10.1126/science.1192152 Loeys, 2005, A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2, Nature Gen, 37, 275, 10.1038/ng1511 Pepin, 2000, Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type, New Eng J Med, 342, 673, 10.1056/NEJM200003093421001 Germain, 2007, Ehlers-Danlos syndrome type IV, Orphanet J Rare Dis, 2, 32, 10.1186/1750-1172-2-32 Loeys, 2006, Aneurysm syndromes caused by mutations in the TGF-beta receptor, New Eng J Med, 355, 788, 10.1056/NEJMoa055695 Albornoz, 2006, Familial thoracic aortic aneurysms and dissections – incidence, modes of inheritance, and phenotypic patterns, Ann Thorac Surg, 82, 1400, 10.1016/j.athoracsur.2006.04.098 Guo, 2007, Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections, Nature Gen, 39, 1488, 10.1038/ng.2007.6 Zhu, 2006, Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus, Nature Gen, 38, 343, 10.1038/ng1721 He R, Guo DC, Sun W, et al. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg 2008;136:922-9, 9 e1. Pannu, 2007, MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II, Human Mol Gen, 16, 2453, 10.1093/hmg/ddm201 Pannu, 2005, Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections, Circulation, 112, 513, 10.1161/CIRCULATIONAHA.105.537340 Jones, 2009, Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis, J Vasc Res, 46, 119, 10.1159/000151766 Cohn, 2007, Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states, Nature Med, 13, 204, 10.1038/nm1536 Zhou, 2006, Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions, Biochem Biophys Res Comm, 339, 633, 10.1016/j.bbrc.2005.11.060 Subramanian, 2012, Regulation of peroxisome proliferator-activated receptor-gamma by angiotensin II via transforming growth factor-beta1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells, Atheroscler Thromb Vasc Biol, 32, 397, 10.1161/ATVBAHA.111.239897 O'Rourke, 2011, Modulating the MicroRNArchitecture of an aging aorta, Circ Res, 109, 1098, 10.1161/CIRCRESAHA.111.256388 Merk, 2012, miR-29b participates in early aneurysm development in Marfan syndrome, Circ Res, 110, 312, 10.1161/CIRCRESAHA.111.253740 Jones, 2011, Selective microRNA suppression in human thoracic aneurysms: relationship of miR-29a to aortic size and proteolytic induction, Circ Cardiovasc Gen, 4, 605, 10.1161/CIRCGENETICS.111.960419